Position in JNJ
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$451,364,326
+$77,429,477 QoQ
Shares Held
1,846,524
+2.2% QoQ
Ownership
0.077%
of shares outstanding
% of Portfolio
1.19%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 59.31295775197073.ToString("F0")%
Shared 10.369700041808285.ToString("F0")%
None 30.31734220622099.ToString("F0")%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Derivatives in JNJ
reported options exposure · as of Mar 31, 2026CallValue
$0
CallShares
0
PutValue
$366,660
PutShares
1,500
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Cerity Partners LLC holds $2,080,837,635 across 16 Drug Manufacturers - General names. JNJ ranks #2 (21.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
732,549 | $673,776,592 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
1,846,524 | $451,364,326 | |
| 3 | ABBV |
AbbVie Inc.
|
1,215,422 | $264,342,129 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,639,510 | $197,216,656 | |
| 5 | AMGN |
Amgen Inc
|
433,555 | $152,546,325 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
1,392,773 | $84,471,681 | |
| 7 | AZN |
Astrazeneca PLC
|
301,215 | $59,405,621 | |
| 8 | NVS |
Novartis AG
|
329,910 | $50,393,751 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $451,364,326 | 1,846,524 | Shares | Sole | 2026-05-15 | |
| 2026-03-31 | $366,660 | 1,500 | Put | Sole | 2026-05-15 | |
| 2025-12-31 | $373,934,849 | 1,806,885 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $330,537,850 | 1,782,644 | Shares | Other | 2025-10-22 | |
| 2025-06-30 | $276,716,401 | 1,811,564 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $293,887,054 | 1,772,112 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $208,248,027 | 1,439,967 | Shares | Other | 2025-02-13 | |
| 2024-09-30 | $236,458,504 | 1,459,080 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $193,938,388 | 1,326,891 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $215,914,954 | 1,364,909 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $250,661,586 | 1,599,219 | Shares | Other | 2024-01-26 | |
| 2023-09-30 | $141,773,618 | 910,264 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $183,009,836 | 1,105,666 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $147,395,080 | 950,936 | Shares | Other | 2023-05-11 | |
| 2022-12-31 | $144,644,376 | 818,819 | Shares | Other | 2023-02-15 | |
| 2022-09-30 | $81,861,002 | 501,108 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $89,004,934 | 501,408 | Shares | Other | 2022-08-10 | |
| 2022-03-31 | $51,852,535 | 292,572 | Shares | Sole | 2022-04-25 | |
| 2021-12-31 | $62,839,656 | 367,333 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $39,079,447 | 241,978 | Shares | Sole | 2021-10-25 | |
| 2021-06-30 | $40,497,375 | 245,826 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $40,680,733 | 247,525 | Shares | Sole | 2021-08-11 | |
| 2020-12-31 | $18,620,099 | 118,313 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $16,587,465 | 111,415 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $10,101,171 | 71,828 | Shares | Sole | 2020-08-17 | |
| 2020-03-31 | $9,914,345 | 75,607 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||